Product class: Authorized package
Medicinal product class: For human use
Package code: 1064696
Name of medicinal product: CETROTIDE
Active substances:
Estonian, English, Latin
ATC code: H01CC02
Dosage form: powder and solvent for solution for injection
Route of administration: subcutaneous use
Strengh: 0,25mg
Amount in package: 7TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information: lahusti süstlis 1 ml
Indication: Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques. In clinical trials Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicule-stimulating hormone (FSH) suggested similar efficacy.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Merck Europe B.V. 
Marketing authorization number: EU/1/99/100 
Marketing authorization issued on: 27 August 1999 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: 05 September 2018
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription